Search
-
What the Future: Wellness
Read more about how technology and changing policy priorities are shaping everything from future healthcare to food, and how providers and companies can adapt.
-
AI in Advertising Research
Read how AI ad evaluation tools can be more connected to human creativity, used more widely in advertising research, and in turn, help brands to get to more effective advertising.
-
Insights to Help You Unlock the Power of New Canadians
Newcomers are the fastest growing segment of the Canadian market. The first step to winning with newcomers and building loyalty is understanding their perspectives and experiences.
-
A Dose of Digital: Can Pharma Make DTx a Healthy Business?
Digital therapeutics (DTx) are emerging as a potential game-changer in healthcare, offering evidence-based digital interventions to help prevent, manage, or treat specific conditions.
-
The Vibrant Fringes: Spotting opportunities beyond the mainstream
Listening to individuals from the fringes can allow marketers to address an underserved market while also uncovering new opportunities and innovations to build brand equity.
-
Understanding the context of consumption moments
A more accurate, granular, and timely understanding of context is increasingly critical to developing strategies that stand out, and ensuring your brand success.
-
Food & Beverage Trends Reports: Off the Shelf
Our series of trends reports help brands stay attuned to macroeconomic, societal and consumer forces to ensure that product strategies remain relevant to consumers' changing tastes.
-
ESG Strategies & Brand Building with New Canadians
Revisit our on demand webinar for insights from the Ipsos New Canadians Research Community, a 200+ member online community of new-to-Canada residents.
-
Sustainability and Advertising: Friends or Foe?
Listen in as we share insights exploring how brands can maximize the impact of sustainability communications.
-
Oncology: the disease, dynamics & challenges of market research
The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved – from patients and their carers to cancer treaters to the companies who manufacture and market treatments.